Home › Funds › Eurizon Capital SGR S.p.A. › ABBV

Eurizon Capital SGR S.p.A. position in ABBV

Abbvie Inc · Health Care

Eurizon Capital SGR S.p.A. reported holding 1,414,037 shares of ABBV (Abbvie Inc) in its Q3 2026 13F filing — a position valued at US$370.6M, representing 0.98% of its reported portfolio and ranking #18 among its reported holdings. Eurizon Capital SGR S.p.A. has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.41M sh
Reported value held$370.62M
Portfolio Weight0.98%
First reportedQ4 2025
Last changeReduce
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How Eurizon Capital SGR S.p.A.'s ABBV position evolved

Eurizon Capital SGR S.p.A. first disclosed a stake in ABBV in Q4 2025 at 1,554,089 shares (US$355.5M). The position peaked in Q2 2026 at 1,515,159 shares, worth US$382.3M. Across 4 filings, Eurizon Capital SGR S.p.A. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,414,037 shares valued at US$370.6M — a reduction of -101,122 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.55M $355.45M New
Q1 2026 1.50M $324.70M Reduce
Q2 2026 1.52M $382.27M Add
Q3 2026 1.41M $370.62M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (Abbvie Inc) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Eurizon Capital SGR S.p.A. held ABBV?

Eurizon Capital SGR S.p.A. has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Eurizon Capital SGR S.p.A.'s current position in ABBV?

As of Q3 2026, Eurizon Capital SGR S.p.A. holds 1.41M shares of ABBV (Abbvie Inc), valued at $370.62M, representing 0.98% of its reported portfolio and ranking #18.

Has Eurizon Capital SGR S.p.A. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Eurizon Capital SGR S.p.A. reduced its position in ABBV. The position peaked in Q2 2026 at 1.52M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.